These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8831505)
21. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells. Shofuda KI; Hasenstab D; Kenagy RD; Shofuda T; Li ZY; Lieber A; Clowes AW FASEB J; 2001 Sep; 15(11):2010-2. PubMed ID: 11511522 [TBL] [Abstract][Full Text] [Related]
22. Generating antibodies against secreted proteins using vascular smooth muscle cells transduced with replication-defective retrovirus. Forough R; Hasenstab D; Koyama N; Lea H; Clowes M; Clowes AW Biotechniques; 1996 Apr; 20(4):694-701. PubMed ID: 8800691 [TBL] [Abstract][Full Text] [Related]
23. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor. Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101 [TBL] [Abstract][Full Text] [Related]
24. Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity. Pross C; Farooq MM; Angle N; Lane JS; Cerveira JJ; Xavier AE; Freischlag JA; Law RE; Gelabert HA J Surg Res; 2002 Feb; 102(2):57-62. PubMed ID: 11795999 [TBL] [Abstract][Full Text] [Related]
25. The synthetic metalloproteinase inhibitor batimastat suppresses injury-induced phosphorylation of MAP kinase ERK1/ERK2 and phenotypic modification of arterial smooth muscle cells in vitro. Lövdahl C; Thyberg J; Hultgârdh-Nilsson A J Vasc Res; 2000; 37(5):345-54. PubMed ID: 11025397 [TBL] [Abstract][Full Text] [Related]
26. TAS-301, an inhibitor of smooth muscle cell migration and proliferation, inhibits intimal thickening after balloon injury to rat carotid arteries. Muranaka Y; Yamasaki Y; Nozawa Y; Terakawa H; Tanahashi Y; Oda N; Satoh A; Asao T; Miyake H; Matsuura N J Pharmacol Exp Ther; 1998 Jun; 285(3):1280-6. PubMed ID: 9618434 [TBL] [Abstract][Full Text] [Related]
27. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury. Mountain DJ; Freeman MB; Kirkpatrick SS; Cook RB; Chalk JE; Stevens SL; Goldman MH; Grandas OH Ann Vasc Surg; 2013 Apr; 27(3):337-45. PubMed ID: 23088810 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Yan Z; Hansson GK Circ Res; 1998 Jan 9-23; 82(1):21-9. PubMed ID: 9440701 [TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells. Koyama N; Kinsella MG; Wight TN; Hedin U; Clowes AW Circ Res; 1998 Aug; 83(3):305-13. PubMed ID: 9710123 [TBL] [Abstract][Full Text] [Related]
30. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. Camozzi M; Zacchigna S; Rusnati M; Coltrini D; Ramirez-Correa G; Bottazzi B; Mantovani A; Giacca M; Presta M Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1837-42. PubMed ID: 16020751 [TBL] [Abstract][Full Text] [Related]
31. [Adenovirus-mediated transfer of TIMP-4 gene inhibits neointimal formation after balloon injury]. Guo Y; Li Q; Chen G; Tang J; Gao W Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):434-7. PubMed ID: 12947565 [TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Wang H; Keiser JA Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730 [TBL] [Abstract][Full Text] [Related]
33. A quantitative in vitro model of smooth muscle cell migration through the arterial wall using the human amniotic membrane. Kallenbach K; Fernandez HA; Seghezzi G; Baumann FG; Patel S; Grossi EA; Galloway AC; Mignatti P Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1008-13. PubMed ID: 12676801 [TBL] [Abstract][Full Text] [Related]
35. Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice. Lijnen HR; Soloway P; Collen D Circ Res; 1999 Dec 3-17; 85(12):1186-91. PubMed ID: 10590246 [TBL] [Abstract][Full Text] [Related]
36. Changes in perlecan expression during vascular injury: role in the inhibition of smooth muscle cell proliferation in the late lesion. Kinsella MG; Tran PK; Weiser-Evans MC; Reidy M; Majack RA; Wight TN Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):608-14. PubMed ID: 12615671 [TBL] [Abstract][Full Text] [Related]
37. TIMP-4 is regulated by vascular injury in rats. Dollery CM; McEwan JR; Wang M; Sang QA; Liu YE; Shi YE Circ Res; 1999 Mar; 84(5):498-504. PubMed ID: 10082471 [TBL] [Abstract][Full Text] [Related]
38. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty. Nili N; Cheema AN; Giordano FJ; Barolet AW; Babaei S; Hickey R; Eskandarian MR; Smeets M; Butany J; Pasterkamp G; Strauss BH Am J Pathol; 2003 Sep; 163(3):869-78. PubMed ID: 12937128 [TBL] [Abstract][Full Text] [Related]
39. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. Jawien A; Bowen-Pope DF; Lindner V; Schwartz SM; Clowes AW J Clin Invest; 1992 Feb; 89(2):507-11. PubMed ID: 1531345 [TBL] [Abstract][Full Text] [Related]
40. Shear stress downregulation of platelet-derived growth factor receptor-beta and matrix metalloprotease-2 is associated with inhibition of smooth muscle cell invasion and migration. Palumbo R; Gaetano C; Melillo G; Toschi E; Remuzzi A; Capogrossi MC Circulation; 2000 Jul; 102(2):225-30. PubMed ID: 10889135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]